ANTHONY ZIEJA, OD
Optometrist in GILFORD, New Hampshire. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ANTHONY ZIEJA, OD reported a CMS MIPS final score of 99.5716/100 — above the 83.1 national average — and filed 477 Medicare Part D claims in 2023.
- 99.5716/100
- MIPS score · +16 vs avg
- 477
- Part D claims, 2023
- 64%
- generic prescribing
- $23.71
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ANTHONY ZIEJA, OD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
100 Top 9% higher than 91% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about ANTHONY ZIEJA, OD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Hampshire
How Optometrist compares to other specialties among New Hampshire providers
Optometrist share within New Hampshire
Optometrist is one of the more visible NUCC categories in New Hampshire
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
ANTHONY ZIEJA, OD's 2023 MIPS final score plotted against the Optometrist national average
- MIPS Final Score
- 99.5716/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Optometrist) — 99.5716/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Optometrist US NPIs
99.5716/100 MIPS final score — 16.5 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Optometrist. Quality dim: 99.1431.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ANTHONY ZIEJA, OD appears in the CMS NPPES registry as a Optometrist provider holding OD credentials at 368 HOUNSELL AVE, GILFORD, NH, 03249, with a listed phone of (603) 528-2606. NPI 1942432323 was issued on 08/18/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ZIEJA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 477 prescription claims written by this provider, covering 111 Medicare beneficiaries and totaling roughly $92K in drug spend, split 36% brand-name and 64% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 99.5716/100 for the 2023 performance year (Quality 99.1431), compared with the national average of 83.1.
Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1942432323 |
|---|---|
| Specialty | Optometrist |
| Credentials | OD |
| Gender | Male |
| NPI Issued | 08/18/2009 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ANTHONY ZIEJA, OD's current license status, disciplinary history, and board certifications with the New Hampshire Board of Medicine in New Hampshire before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where ANTHONY ZIEJA, OD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ANTHONY ZIEJA, OD. Source: openpaymentsdata.cms.gov.
Total received
$24
Largest payer
Alcon Vision LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
36% brand-name claims vs 64% generic, on 477 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,042
- Total Day Supply
- 30,555
- Brand vs Generic
- 36% brand / 64% generic
- Brand Drug Cost
- $81K
- Generic Drug Cost
- $12K
Patient Demographics
- Average Patient Age
- 75.6 years
- Avg HCC Risk Score
- 0.77
- Gender Split
- 64% female / 36% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What ANTHONY ZIEJA, OD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
173 claims
- Timolol Maleate 67
Timolol Maleate
67 claims
- Dorzolamide-Timolol 64
Dorzolamide-Timolol
64 claims
- Brimonidine Tartrate 40
Brimonidine Tartrate
40 claims
- Lumigan 22
Lumigan
22 claims
- Restasis 19
Restasis
19 claims
- Travatan Z 18
Travatan Z
18 claims
- Rhopressa 12
Rhopressa
12 claims
| Drug | Claims |
|---|---|
| Latanoprost | 173 |
| Timolol Maleate | 67 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 64 |
| Brimonidine Tartrate | 40 |
| Lumigan Bimatoprost | 22 |
| Restasis Cyclosporine | 19 |
| Travatan Z Travoprost | 18 |
| Rhopressa Netarsudil Mesylate | 12 |
| Xiidra Lifitegrast | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How ANTHONY ZIEJA, OD fits within the Optometrist landscape nationally.
ANTHONY ZIEJA, OD's 477 claims are above the specialty average of 257.
Nearby Optometrist Providers in New Hampshire
Other clinicians with the same primary specialty enrolled in New Hampshire, drawn from the same CMS NPPES roster as ZIEJA.
Compare Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Hampshire
Frequently Asked Questions
What is ANTHONY ZIEJA, OD's specialty? ▼
How much does ANTHONY ZIEJA, OD prescribe under Medicare Part D? ▼
What is ANTHONY ZIEJA, OD's Medicare quality score? ▼
Where is ANTHONY ZIEJA, OD located? ▼
What is ANTHONY ZIEJA, OD's NPI number? ▼
Does ANTHONY ZIEJA, OD prescribe more brand-name or generic drugs? ▼
How many Optometrist providers are there in the US? ▼
What drugs does ANTHONY ZIEJA, OD prescribe most often? ▼
Does ANTHONY ZIEJA, OD accept Medicare? ▼
How can I verify ANTHONY ZIEJA, OD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology